---
title: "Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294365645.md"
description: "On July 30, 2026, in Florham Park, N.J., Cellectar Biosciences, Inc. (NASDAQ: CLRB), a company specializing in cancer drug development, shared plans to disclose its financial performance for the second quarter concluding on June 30, 2026. The corporate update, which will include this financial data, is scheduled for August 13, 2026, at 8:30 a.m. Eastern Time. Cellectar Biosciences, Inc. is known for its late-stage clinical biopharmaceutical work."
datetime: "2026-07-30T12:10:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294365645.md)
  - [en](https://longbridge.com/en/news/294365645.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294365645.md)
generator: "portal-rs"
---

# Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026

On July 30, 2026, in Florham Park, N.J., Cellectar Biosciences, Inc. (NASDAQ: CLRB), a company specializing in cancer drug development, shared plans to disclose its financial performance for the second quarter concluding on June 30, 2026. The corporate update, which will include this financial data, is scheduled for August 13, 2026, at 8:30 a.m. Eastern Time. Cellectar Biosciences, Inc. is known for its late-stage clinical biopharmaceutical work.

### Related Stocks

- [CLRB.US](https://longbridge.com/en/quote/CLRB.US.md)

## Related News & Research

- [Cellectar Biosciences Q2 2026 Earnings Call Transcript](https://longbridge.com/en/news/295806334.md)
- [Cellectar Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates | CLRB Stock News](https://longbridge.com/en/news/295789747.md)
- [Jazz Pharmaceuticals Acquires Actio Biosciences to Expand Epilepsy Portfolio](https://longbridge.com/en/news/299065741.md)
- [Exelixis Stock Slips as FDA Delays Cancer Drug Review, Analyst Weighs In](https://longbridge.com/en/news/298761132.md)
- [Sherwin-Williams announces Q3 2026 dividend of R$ 0.28 per unit](https://longbridge.com/en/news/299050724.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**